COIL — Coiled Therapeutics Share News
0.000.00%
Roquefort Theraptcs. - Interim Results to 30 June 2024
Brief: Roquefort Therapeutics Says STAT-6 SIRNA Shows Efficacy In Immunology Model
Roquefort Theraptcs. - Notice of Annual General Meeting
Brief: Roquefort Theraptcs - Midkine Antibody Licencing Deal
Roquefort Theraptcs. - Issue of Convertible Loan Notes & Board Changes
Roquefort Theraptcs. - Midkine Antibody Licencing Deal
Roquefort Theraptcs. - Annual Report & Financial Statements - 31 Dec 2023
Brief: Roquefort Therapeutics Not To Proceed With Potential Placing
Roquefort Theraptcs. - Response to Share Price Movement
Brief: Roquefort Therapeutics Engaged In Confidential Out-Licencing Discussions With Potential Partners
Roquefort Theraptcs. - Operations Update
Brief: Roquefort Therapeutics Says Hy Net Loss Of £742,833
Roquefort Theraptcs. - Interim Results to 30 June 2023
RCS - Roquefort Theraptcs. - Investor Presentation via Investor Meet Company
Brief: Roquefort Therapeutics Files International Phase PCT Patent For Proprietary Anti-Cancer mRNA, RNA Oligonucleotide Therapeutics
Roquefort Theraptcs. - Director/PDMR Shareholding
Roquefort Theraptcs. - Director/PDMR Shareholding
Roquefort Theraptcs. - AGM Statement
RCS - Roquefort Theraptcs. - Investor Presentation via Investor Meet Company